Alterity Therapeutics issues shares from exercise of listed options at A$0.5 each

• Alterity Therapeutics signed an underwriting deal covering exercise of up to 8,400,000 unexercised ATHO listed options before expiry.
• ATHO options outstanding total 15,918,235; exercise price A$ 0.5; expiry 5:00 p.m. AEST on Aug. 31, 2026.
• Underwriter MST Financial Services will subscribe, or place subscriptions, for shortfall shares up to the 8,400,000-option cap.
• Issuance expected to total 8,400,000 to 15,918,235 new shares; gross proceeds A$ 4.2 million to A$ 7.96 million.
• MST can terminate the underwriting before Sept. 4, 2026 under customary triggers, including breach or a 10% market fall.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alterity Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-029242), on August 31, 2026, and is solely responsible for the information contained therein.